Our Leadership

Leading with passion, expertise, and innovation.

Aizant is driven by a team of highly experienced and dedicated professionals, each bringing their unique expertise to advance our mission of becoming a global leader in pharmaceutical development. Our leadership combines scientific knowledge with strategic vision, guiding the company toward continued innovation and excellence.

Meet the Leadership

Dr. Varma S. RudrarajuChairman & Managing Director

  • Over 25 years of experience in the pharmaceutical industry, having worked with Syntex Inc./Hoffman-La Roche, DuPont Merck/BMS Pharmaceuticals in the USA, and Aizant in India.
  • Key contributor to the USFDA collaboration program for training USFDA chemists and investigators.
  • Founding member of the advanced development and manufacturing practices consortium (USFDA/MIT/Purdue University and Industry).
  • Advocate for Quality by Design (QbD) and Process Analytical Technology (PAT) in the healthcare sector.
  • Speaker at international scientific conferences.

Dr. Santanu De Chief Growth Officer

  • Over 25 years of experience in the pharmaceutical industry, with a unique blend of scientific and legal expertise, holding a Ph.D. in Organic Chemistry and an LLB from the University of Delhi.
  • Has held leadership positions at prominent pharmaceutical companies, driving business growth and strategic initiatives.
  • Expertise spans business development, intellectual property strategy, and chemical research.
  • Managed global product pipelines, IP litigation strategies, and developed cost-effective API production processes.
  • Recognized with multiple industry awards and publications, and has been a speaker at various conferences andsymposiums.

Ramesh Babu M Vice President – Quality

  • Over 25 years of experience in Quality Assurance, Quality Control, and Regulatory Affairs.
  • Successfully led over 100 global regulatory inspections, securing approvals from USFDA, UK MHRA, and WHO Geneva.
  • Instrumental in setting up facilities for CMO, CRO, and CDO verticals.
  • Leads a 150+ strong team in quality assurance, control, and regulatory affairs.

Dr. Hari Raghu Ram Desu Director & Head of Complex Products

  • Over 20 years of experience in developing both generic and innovative complex products.
  • Previous roles include Dr. Reddy’s, InnoPharma (Pfizer, USA), and Plough Center (USA).
  • Extensive work on small molecule-based APIs, biologics (peptides, proteins, antibodies), and drug-device combinations.
  • Holds a Ph.D. in Drug Design and Pharmaceutics from the University of Tennessee, Memphis, USA.
  • Published research in international journals and co-authoredbook chapters.

Dr. Tausif Ahmed Senior Vice President—BA/BE Operations

  • Over 24 years of experience in the pharmaceutical industry, specializing in the preclinical and clinical development of NCEs, generics, and complex products.
  • Former VP & Head of Preclinical, Biopharmaceutics, and Bioequivalence at Ranbaxy (Sun Pharma), Sai Life Sciences, Piramal Life Sciences, and Dr. Reddy’s Laboratories.
  • Experience working with regulatory agencies (EMA, USFDA, ANVISA, NPRA, NMPA) on clinico-regulatory strategies.
  • Authored 60+ articles in peer-reviewed journals, including collaborations with USFDA and global pharma.
  • Managed 200+ BA/BE and clinical studies annually.
  • Expertise in biopharmaceutics risk assessment and PBPK modeling.
  • Invited speaker at national and international conferences.

Leadership Philosophy

Our leadership team fosters a culture of collaboration, transparency, and innovation. Each leader brings a unique combination of scientific expertise, industry experience, and strategic insight that drives our company forward. Through collective efforts, we work towards Aizant’s vision of becoming a global leader in pharmaceutical development, ensuring that our clients, partners receive exceptional solutions and support at every stage of drug development journey.